Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis

التفاصيل البيبلوغرافية
العنوان:	Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis
المؤلفون:	Yin Yang, Jianyang Wang, Wenqing Wang, Tao Zhang, Jingjing Zhao, Yu Wang, Yexiong Li, Luhua Wang, Nan Bi
المصدر:	Frontiers in Oncology, Vol 12 (2022)
بيانات النشر:	Frontiers Media S.A., 2022.
سنة النشر:	2022
المجموعة:	LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية:	Limited-stage small-cell lung cancer, surrogate endpoint, overall survival, progression-free survival, time to progression, chemoradiotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
نوع الوثيقة:	article
وصف الملف:	electronic resource
اللغة:	English
تدمد:	2234-943X
العلاقة:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1007862/fullTest; https://doaj.org/toc/2234-943XTest
DOI:	10.3389/fonc.2022.1007862
الوصول الحر:	https://doaj.org/article/d945687fc1ba4b6ca0be33f590f5a185Test
رقم الانضمام:	edsdoj.945687fc1ba4b6ca0be33f590f5a185
قاعدة البيانات:	Directory of Open Access Journals

الوصف
تدمد:	2234943X
DOI:	10.3389/fonc.2022.1007862